Page last updated: 2024-11-06

cyclopropylamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyclopropylamine: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyclopropylamine : A primary aliphatic amine that consists of cyclopropane bearing a single amino substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID69828
CHEBI ID34660
MeSH IDM0184633

Synonyms (46)

Synonym
nsc 56127
einecs 212-142-2
nsc56127
765-30-0
cyclopropanamine
nsc-56127
aminocyclopropane
cyclopropylamine
inchi=1/c3h7n/c4-3-1-2-3/h3h,1-2,4h2
htjdqjbwanprpf-uhfffaoysa-
cyclopropylamine, 98%
AKOS000119334
cyclopropyl amine
STL168345
AM804333
ec 212-142-2
unii-8pr8xth1x1
8pr8xth1x1 ,
BP-10575
CHEBI:34660
cyclopropyl-amine
cyclopropyl amin
cyclopropane amine
cyclopropaneamine
n-cyclopropylamine
cyclopropylamin
cyclopropylarnine
cyclopropyamine
cycloproplyamine
cylopropylamine
3-cyclopropylamine
DTXSID9061099
STR00451
mfcd00001301
J-520185
F2190-0503
GEO-00889
CS-D1450
Q1147604
EN300-21353
P19977
PB47448
cyclopropyl--d4-amine
cyclopropanamine-d5
mfcd28009728
SY344664

Research Excerpts

Overview

Cyclopropylamine is a mechanism-based inhibitor of the quinoprotein methylamine dehydrogenase (MADH) from Paracoccus denitrificans.

ExcerptReferenceRelevance
"Cyclopropylamine is a mechanism-based inhibitor of the quinoprotein methylamine dehydrogenase (MADH) from Paracoccus denitrificans. "( Inter-subunit cross-linking of methylamine dehydrogenase by cyclopropylamine requires residue alphaPhe55.
Davidson, VL; Sun, D, 2002
)
2

Actions

ExcerptReferenceRelevance
"Cyclopropylamines inactivate cytochrome P450 enzymes which catalyze their oxidative N-dealkylation. "( N-dealkylation of an N-cyclopropylamine by horseradish peroxidase. Fate of the cyclopropyl group.
Hanzlik, RP; Morton, MD; Shaffer, CL, 2001
)
2.06
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
primary aliphatic amine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
Abacavir ADME624
Abacavir metabolism423
Drug ADME6387

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (7.69)18.7374
1990's1 (1.92)18.2507
2000's23 (44.23)29.6817
2010's20 (38.46)24.3611
2020's4 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.63 (24.57)
Research Supply Index3.97 (2.92)
Research Growth Index6.10 (4.65)
Search Engine Demand Index70.00 (26.88)
Search Engine Supply Index1.99 (0.95)

This Compound (48.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.85%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]